SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2026-02-11 13:52Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Kaili Medical (300633), indicating a decline in stock price and mixed financial results [1][2]. - As of February 11, 2026, Kaili Medical's stock closed at 26.8 yuan, down 1.29%, with a turnover rate of 0.75% and a trading volume of 32,300 hands, resulting in a transaction amount of 87.27 million yuan [1]. - The net inflow of funds on February 11 showed that institutional funds had a net inflow of 1.1 million yuan, accounting for 1.26% of the total transaction amount, while retail investors experienced a net outflow of 9.36 million yuan, representing 10.73% of the total transaction amount [1]. Group 2 - In the third quarter of 2025, Kaili Medical reported a main operating income of 1.459 billion yuan, a year-on-year increase of 4.37%, but the net profit attributable to shareholders decreased by 69.25% to 33.51 million yuan [2]. - The third quarter also saw a single-quarter main operating income of 495 million yuan, up 28.42% year-on-year, while the single-quarter net profit attributable to shareholders was -13.52 million yuan, reflecting a year-on-year increase of 78.05% [2]. - The company has a debt ratio of 24.22%, with investment income of 2.08 million yuan and financial expenses of -38.30 million yuan, alongside a gross profit margin of 60.36% [2]. Group 3 - Over the last 90 days, four institutions have provided ratings for Kaili Medical, with three giving a "buy" rating and one an "increase" rating [3]. - The article explains the concept of fund flow, indicating that the difference between fund inflow and outflow reflects the net force driving stock price changes [3].